Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. (Q39891975)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. |
scientific article |
Statements
Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference